Efficacy and resistance in de novo combination lamivudine and adefovir dipivoxil therapy versus entecavir monotherapy for the treatment-naive patients with chronic hepatitis B: a meta-analysis

類似資料

• De novo combined lamivudine and adefovir dipivoxil therapy vs entecavir monotherapy for hepatitis B virus-related decompensated cirrhosis
  著者:: Lian, Jiang-Shan, 等
  出版事項: (2013)
• De novo entecavir+adefovir dipivoxil+lamivudine triple-resistance mutations resulting from sequential therapy with adefovir dipivoxil, and lamivudine
  著者:: Yang, Song, 等
  出版事項: (2016)
• De novo combination of lamivudine and adefovir versus entecavir monotherapy for the treatment of naïve HBeAg-negative chronic hepatitis B patients
  著者:: Wang, Li-Chun, 等
  出版事項: (2011)
• Lamivudine plus adefovir combination therapy versus entecavir monotherapy for lamivudine-resistant chronic hepatitis B: a systematic review and meta-analysis
  著者:: Sheng, Yun-Jian, 等
  出版事項: (2011)
• De novo combination therapy with lamivudine and adefovir dipivoxil in chronic hepatitis B patients
  著者:: Fan, Xiao-Hong, 等
  出版事項: (2011)